Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

One of the pillars of modern medicine is the life-saving drugs that pharmaceutical companies spend years developing to cure ...

In this article, we are going to take a look at where Conduit Pharmaceuticals Inc. (NASDAQ:CDT) stands against the other AI ...

In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI discusses ...

Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii).

LB Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing novel therapies for the treatment of ...

Simply sign up to the Pharmaceuticals sector myFT ... to strengthen the company’s ability to produce drugs through internal research and development, but Gross acknowledged this would take ...

Middle molecules with a molecular weight of more than 1,000 are difficult to synthesize due to multiple steps and time-consuming nature, demanding the development of a new approach that can overcome ...

Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process ...

and innovative drug development. About Conduit Pharmaceuticals Conduit is a dynamic, multi-asset clinical stage, life science company delivering an efficient model for compound development.

Draft Pharma Policy 2025 of Odisha encourages ease of doing businesses: Peethaambaran Kunnathoor, Chennai Wednesday, February 12, 2025, 08:00 Hrs [IST] Following the ‘Make-in-Od ...